LARISSA ALEJANDRAMEYERLARISSA ALEJANDRA MEYER9431MEYER, LARISSA ALEJANDRAAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1155 Pressler StHouston77030-3721TXAuthorship 1757313Authorship 1777641Authorship 1829187Authorship 1831644Authorship 1864902Authorship 1883304Authorship 1892407Authorship 190209517618772Meyer L, Ascher-Walsh CJ, Norman R, Idrissa A, Herbert H, Kimso O, Wilkinson JAmerican journal of obstetrics and gynecologyCommonalities among women who experienced vesicovaginal fistulae as a result of obstetric trauma in Niger: results from a survey given at the National Hospital Fistula Center, Niamey, Niger. Am J Obstet Gynecol. 2007 Jul; 197(1):90.e1-4.Am J Obstet Gynecol2007-07-01T00:00:002007Commonalities among women who experienced vesicovaginal fistulae as a result of obstetric trauma in Niger: results from a survey given at the National Hospital Fistula Center, Niamey, Niger.Gynecological Oncology & Reproductive MedicineHealth Services ResearchPalliative Care & Rehabilitation MedicineMD AndersonPEDRO TOMASRAMIREZPEDRO TOMAS RAMIREZ8779RAMIREZ, PEDRO TOMASProfessorCHARLOTTE CSUNCHARLOTTE C SUN8695SUN, CHARLOTTE CAssociate ProfessorEDUARDOBRUERAEDUARDO BRUERA8804BRUERA, EDUARDOProfessorKAREN HLUKAREN H LU8836LU, KAREN HProfessorROBERTCOLEMANROBERT COLEMAN9184COLEMAN, ROBERTProfessorSHARON HERMESGIORDANOSHARON HERMES GIORDANO8843GIORDANO, SHARON HERMESProfessorANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessorSHANNON NEVILLEWESTINSHANNON NEVILLE WESTIN9337WESTIN, SHANNON NEVILLEAssociate Professor6.507320.00854455433research areas6.460110.021874990coauthor of317.57731.10260similar to11148selected publicationsAuthorship 2229241Authorship 2248634Authorship 2279091Authorship 233805616455022Meyer L, Pothuri BCurrent treatment options in oncologyDecompressive percutaneous gastrostomy tube use in gynecologic malignancies. Curr Treat Options Oncol. 2006 Mar; 7(2):111-20.Curr Treat Options Oncol2006-03-01T00:00:002006Decompressive percutaneous gastrostomy tube use in gynecologic malignancies.18588460Meyer LA, Westin SN, Lu KH, Milam MRExpert review of anticancer therapyGenetic polymorphisms and endometrial cancer risk. Expert Rev Anticancer Ther. 2008 Jul; 8(7):1159-67.Expert Rev Anticancer Ther2008-07-01T00:00:002008Genetic polymorphisms and endometrial cancer risk.18684498Lacour RA, Daniels MS, Westin SN, Meyer LA, Burke CC, Burns KA, Kurian S, Webb NF, Pustilnik TB, Lu KHGynecologic oncologyWhat women with ovarian cancer think and know about genetic testing. Gynecol Oncol. 2008 Oct; 111(1):132-6.Gynecol Oncol2008-08-06T00:00:002008What women with ovarian cancer think and know about genetic testing.23500454Zhang Q, Celestino J, Schmandt R, McCampbell AS, Urbauer DL, Meyer LA, Burzawa JK, Huang M, Yates MS, Iglesias D, Broaddus RR, Lu KHAmerican journal of obstetrics and gynecologyChemopreventive effects of metformin on obesity-associated endometrial proliferation. Am J Obstet Gynecol. 2013 Jul; 209(1):24.e1-24.e12.Am J Obstet Gynecol2013-03-15T00:00:002013Chemopreventive effects of metformin on obesity-associated endometrial proliferation.Authorship 2472479Authorship 2521731Authorship 2553032Authorship 2560275Authorship 261883715126331Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, Mansukhani M, Villella J, Meyer L, Schneider A, Gissmann L, D?rst M, Pothuri B, Murty VVCancer researchPromoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res. 2004 May 01; 64(9):2994-7.Cancer Res2004-05-01T00:00:002004Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.19078925Meyer LA, Broaddus RR, Lu KHCancer control : journal of the Moffitt Cancer CenterEndometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control. 2009 Jan; 16(1):14-22.Cancer Control2009-01-01T00:00:002009Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.20606085Hennessy BT, Timms KM, Carey MS, Gutin A, Meyer LA, Flake DD, Abkevich V, Potter J, Pruss D, Glenn P, Li Y, Li J, Gonzalez-Angulo AM, McCune KS, Markman M, Broaddus RR, Lanchbury JS, Lu KH, Mills GBJournal of clinical oncology : official journal of the American Society of Clinical OncologySomatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer. J Clin Oncol. 2010 Aug 01; 28(22):3570-6.J Clin Oncol2010-07-06T00:00:002010Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.21278312Yates MS, Meyer LA, Deavers MT, Daniels MS, Keeler ER, Mok SC, Gershenson DM, Lu KHCancer prevention research (Philadelphia, Pa.)Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis. Cancer Prev Res (Phila). 2011 Mar; 4(3):463-70.Cancer Prev Res (Phila)2011-01-28T00:00:002011Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.24937481Jones N, Fleming ND, Nick AM, Munsell MF, Rallapalli V, Westin SN, Meyer LA, Schmeler KM, Ramirez PT, Soliman PTGynecologic oncologyConversion from robotic surgery to laparotomy: a case-control study evaluating risk factors for conversion. Gynecol Oncol. 2014 Aug; 134(2):238-42.Gynecol Oncol2014-06-14T00:00:002014Conversion from robotic surgery to laparotomy: a case-control study evaluating risk factors for conversion.Authorship 2662502Authorship 2692671Authorship 269298315385131Pothuri B, Meyer L, Gerardi M, Barakat RR, Chi DSGynecologic oncologyReoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma. Gynecol Oncol. 2004 Oct; 95(1):193-5.Gynecol Oncol2004-10-01T00:00:002004Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.20410767Meyer LA, Anderson ME, Lacour RA, Suri A, Daniels MS, Urbauer DL, Nogueras-Gonzalez GM, Schmeler KM, Gershenson DM, Lu KHObstetrics and gynecologyEvaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol. 2010 May; 115(5):945-952.Obstet Gynecol2010-05-01T00:00:002010Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.21276604Lacour RA, Westin SN, Meyer LA, Wingo SN, Schorge JO, Brooks R, Mutch D, Molina A, Sutphen R, Barnes M, Elder J, Teoh D, Powell CB, Choubey V, Blank S, Macdonald HR, Brady MF, Urbauer DL, Bodurka D, Gershenson DM, Lu KHGynecologic oncologyImproved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations. Gynecol Oncol. 2011 May 01; 121(2):358-63.Gynecol Oncol2011-01-28T00:00:002011Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.Authorship 28880612Authorship 2930434Authorship 2939761Authorship 2963008Authorship 2967884Authorship 29856213Authorship 2995542Authorship 2996423Authorship 2997533Authorship 3007604Authorship 3019513Authorship 3034864Authorship 305898124651628Meyer LA, Slomovitz BM, Djordjevic B, Westin SN, Iglesias DA, Munsell MF, Jiang Y, Schmandt R, Broaddus RR, Coleman RL, Galbincea JM, Lu KHInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyThe search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer. Int J Gynecol Cancer. 2014 May; 24(4):713-7.Int J Gynecol Cancer2014-05-01T00:00:002014The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.25446609Bishop AJ, Allen PK, Klopp AH, Meyer LA, Eifel PJInternational journal of radiation oncology, biology, physicsRelationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated? Int J Radiat Oncol Biol Phys. 2015 Jan 01; 91(1):196-205.Int J Radiat Oncol Biol Phys2014-10-25T00:00:002014Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated?25647455Meyer LA, Nick AM, Shi Q, Wang XS, Williams L, Brock T, Iniesta MD, Rangel K, Lu KH, Ramirez PTGynecologic oncologyPerioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients. Gynecol Oncol. 2015 Mar; 136(3):440-5.Gynecol Oncol2015-01-31T00:00:002015Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients.25867973Wang Y, Ye Y, Lin J, Meyer L, Wu X, Lu K, Liang DMolecular carcinogenesisGenetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome. Mol Carcinog. 2015 Jun; 54(6):430-9.Mol Carcinog2013-11-19T00:00:002013Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.25968823Smith GL, Jiang J, Giordano SH, Meyer LA, Eifel PJInternational journal of radiation oncology, biology, physicsTrends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):260-7.Int J Radiat Oncol Biol Phys2015-06-01T00:00:002015Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011.26150442Meyer LA, Bohlke K, Powell MA, Fader AN, Franklin GE, Lee LJ, Matei D, Coallier L, Wright AAJournal of clinical oncology : official journal of the American Society of Clinical OncologyPostoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. J Clin Oncol. 2015 Sep 10; 33(26):2908-13.J Clin Oncol2015-07-06T00:00:002015Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.26197762Arms RG, Sun CC, Burzawa JK, Fleming ND, Nick AM, Rallapalli V, Westin SN, Meyer LA, Ramirez PT, Soliman PTGynecologic oncologyImprovement in quality of life after robotic surgery results in patient satisfaction. Gynecol Oncol. 2015 Sep; 138(3):727-30.Gynecol Oncol2015-07-18T00:00:002015Improvement in quality of life after robotic surgery results in patient satisfaction.26240233Wright AA, Cronin A, Milne DE, Bookman MA, Burger RA, Cohn DE, Cristea MC, Griggs JJ, Keating NL, Levenback CF, Mantia-Smaldone G, Matulonis UA, Meyer LA, Niland JC, Weeks JC, O'Malley DMJournal of clinical oncology : official journal of the American Society of Clinical OncologyUse and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2015 Sep 10; 33(26):2841-7.J Clin Oncol2015-08-03T00:00:002015Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer.26307402Rauh-Hain JA, Starbuck KD, Meyer LA, Clemmer J, Schorge JO, Lu KH, Del Carmen MGGynecologic oncologyPatterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis. Gynecol Oncol. 2015 Oct; 139(1):84-9.Gynecol Oncol2015-08-22T00:00:002015Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.26325526Rauh-Hain JA, Diver E, Meyer LA, Clemmer J, Lu KH, Del Carmen MG, Schorge JOGynecologic oncologyPatterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: analysis of the National Cancer Database. Gynecol Oncol. 2015 Oct; 139(1):77-83.Gynecol Oncol2015-08-29T00:00:002015Patterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: analysis of the National Cancer Database.26432043Kim YJ, Munsell MF, Park JC, Meyer LA, Sun CC, Brown AJ, Bodurka DC, Williams JL, Chase DM, Bruera E, Ramondetta LMGynecologic oncologyRetrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. Gynecol Oncol. 2015 Dec; 139(3):553-8.Gynecol Oncol2015-09-30T00:00:002015Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer.26498912Ramondetta LM, Meyer LA, Schmeler KM, Daheri ME, Gallegos J, Scheurer M, Montealegre JR, Milbourne A, Anderson ML, Sun CCGynecologic oncologyAvoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer. Gynecol Oncol. 2015 Dec; 139(3):500-5.Gynecol Oncol2015-10-21T00:00:002015Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer.26551187Rauh-Hain JA, Pepin KJ, Meyer LA, Clemmer JT, Lu KH, Rice LW, Uppal S, Schorge JO, Del Carmen MGObstetrics and gynecologyManagement for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer. Obstet Gynecol. 2015 Dec; 126(6):1198-1206.Obstet Gynecol2015-12-01T00:00:002015Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer.15581947Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DCGynecologic oncologyPredictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004 Dec; 95(3):463-8.Gynecol Oncol2004-12-01T00:00:002004Predictors of final histology in patients with endometrial cancer.74Professor10Assistant Professor14Associate Professor26245979Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, Frumovitz MM, Lu KH, Bodurka DCJournal of cancer survivorship : research and practiceSurvivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv. 2016 Apr; 10(2):261-70.J Cancer Surviv2015-08-06T00:00:002015Survivors of gynecologic malignancies: impact of treatment on health and well-being.26906066Miralpeix E, Nick AM, Meyer LA, Cata J, Lasala J, Mena GE, Gottumukkala V, Iniesta-Donate M, Salvo G, Ramirez PTGynecologic oncologyA call for new standard of care in perioperative gynecologic oncology practice: Impact of enhanced recovery after surgery (ERAS) programs. Gynecol Oncol. 2016 05; 141(2):371-378.Gynecol Oncol2016-03-09T00:00:002016A call for new standard of care in perioperative gynecologic oncology practice: Impact of enhanced recovery after surgery (ERAS) programs.19765809Tung CS, Sun CC, Schlumbrecht MP, Meyer LA, Bodurka DCGynecologic oncologySurvival after intestinal perforation: can it be predicted? Gynecol Oncol. 2009 Dec; 115(3):349-53.Gynecol Oncol2009-09-18T00:00:002009Survival after intestinal perforation: can it be predicted?21118967Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, Gu J, Wu X, Lu KCancer researchGenetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res. 2010 Dec 01; 70(23):9765-76.Cancer Res2010-11-30T00:00:002010Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.21324431Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KHAmerican journal of obstetrics and gynecologyProspective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol. 2011 Apr; 204(4):355.e1-7.Am J Obstet Gynecol2011-02-16T00:00:002011Prospective evaluation of insulin resistance among endometrial cancer patients.21984931Yin J, Lu K, Lin J, Wu L, Hildebrandt MA, Chang DW, Meyer L, Wu X, Liang DPloS oneGenetic variants in TGF-? pathway are associated with ovarian cancer risk. PLoS One. 2011; 6(9):e25559.PLoS One2011-09-30T00:00:002011Genetic variants in TGF-? pathway are associated with ovarian cancer risk.Authorship 841422Authorship 841485Authorship 842835Authorship 845042Authorship 845655Authorship 846555Authorship 851365Authorship 851999Authorship 852405Authorship 855271Authorship 859013Authorship 861728Authorship 862190Authorship 865971Authorship 866659Obstetrical and Gynecological SurveyNeoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer. Obstetrical and Gynecological Survey. 71:717-718.Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancerPractical Radiation OncologyImpact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Practical Radiation Oncology. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapyGynecologic OncologyA call for new standard of care in perioperative gynecologic oncology practice. Gynecologic Oncology. A call for new standard of care in perioperative gynecologic oncology practiceAnnals of Surgical OncologyThe DISINFECT Initiative. Annals of Surgical Oncology. 1-7.The DISINFECT InitiativeObstetrical and Gynecological SurveyEvaluating women with ovarian cancer for BRCA1 and BRCA2 mutations missed opportunities. Obstetrical and Gynecological Survey. 65:436-437.Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations missed opportunitiesJournal of Clinical OncologyNeoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer. Journal of Clinical Oncology. 34:3460-3473.Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancerInternational Journal of Gynecological CancerPatterns of care, predictors, and outcomes of adjuvant therapy for early- and advanced-stage uterine clear cell carcinoma. International Journal of Gynecological Cancer. 26:696-704.Patterns of care, predictors, and outcomes of adjuvant therapy for early- and advanced-stage uterine clear cell carcinomaGynecologic OncologyGuidelines for pre- and intra-operative care in gynecologic/oncology surgery. Gynecologic Oncology. 140:313-322.Guidelines for pre- and intra-operative care in gynecologic/oncology surgeryJournal of Oncology PracticePostoperative radiation therapy for endometrial cancer. Journal of Oncology Practice. 12:182-185.Postoperative radiation therapy for endometrial cancerJournal of Oncology PracticeWhat is the real rate of surgical site infection?. Journal of Oncology Practice. 12:e878-e883.What is the real rate of surgical site infection?Journal of Clinical OncologyUse and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancer. Journal of Clinical Oncology. 34:3854-3863.Use and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancerJournal of Cancer SurvivorshipSurvivors of gynecologic malignancies. Journal of Cancer Survivorship. Survivors of gynecologic malignanciesGynecologic OncologyGuidelines for postoperative care in gynecologic/oncology surgery. Gynecologic Oncology. Guidelines for postoperative care in gynecologic/oncology surgeryObstetrical and Gynecological SurveyUse of CA-125 tests and computed tomographic scans for surveillance in ovarian cancer. Obstetrical and Gynecological Survey. 71:660-661.Use of CA-125 tests and computed tomographic scans for surveillance in ovarian cancerGynecologic OncologyNeoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer. Gynecologic Oncology. 143:3-15.Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer19185100Zhang Q, Shen Q, Celestino J, Milam MR, Westin SN, Lacour RA, Meyer LA, Shipley GL, Davies PJ, Deng L, McCampbell AS, Broaddus RR, Lu KHAmerican journal of obstetrics and gynecologyEnhanced estrogen-induced proliferation in obese rat endometrium. Am J Obstet Gynecol. 2009 Feb; 200(2):186.e1-8.Am J Obstet Gynecol2009-02-01T00:00:002009Enhanced estrogen-induced proliferation in obese rat endometrium.22146979Wang LE, Ma H, Hale KS, Yin M, Meyer LA, Liu H, Li J, Lu KH, Hennessy BT, Li X, Spitz MR, Wei Q, Mills GBJournal of cancer research and clinical oncologyRoles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. J Cancer Res Clin Oncol. 2012 Mar; 138(3):377-85.J Cancer Res Clin Oncol2011-12-07T00:00:002011Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.Authorship 8874835Authorship 8878192D005833Disorders1887340.597618Genital Neoplasms, FemaleD010051Disorders61946210.31574Ovarian NeoplasmsD013509Procedures723600.757695Gynecologic Surgical ProceduresAuthorship 90489011Authorship 90492114Authorship 9059533Authorship 9073759Authorship 9077508Authorship 9080461Authorship 9092173Authorship 9113609Authorship 91329511Authorship 9147937Authorship 9172954Authorship 9174944Authorship 9181819Authorship 9206621Authorship 9220831Authorship 9259694Authorship 9284256Authorship 9287926Authorship 9291091Authorship 9333678Authorship 9343078Authorship 935797526825834Gockley AA, Rauh-Hain JA, Anders AM, Meyer LA, Clemmer J, Lu KH, Clark RM, Schorge JO, del Carmen MGInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPatterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis. Int J Gynecol Cancer. 2016 May; 26(4):697-704.Int J Gynecol Cancer2016-05-01T00:00:002016Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis.27460495Taylor JS, Marten CA, Potts KA, Cloutier LM, Cain KE, Fenton SL, Tatum TN, James DA, Myers KN, Hubbs CA, Burzawa JK, Vachhani S, Nick AM, Meyer LA, Graviss LS, Ware KM, Park AK, Aloia TA, Bodurka DC, Levenback CF, Schmeler KMJournal of oncology practiceWhat Is the Real Rate of Surgical Site Infection? J Oncol Pract. 2016 10; 12(10):e878-e883.J Oncol Pract2016-10-01T00:00:002016What Is the Real Rate of Surgical Site Infection?27442965Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Cristea M, Griggs JJ, Levenback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Malley DM, Wright AAJAMA oncologyUse of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. JAMA Oncol. 2016 Nov 01; 2(11):1427-1433.JAMA Oncol2016-11-01T00:00:002016Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.27502591Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MIJournal of clinical oncology : official journal of the American Society of Clinical OncologyNeoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016 10 01; 34(28):3460-73.J Clin Oncol2016-08-08T00:00:002016Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.27573526Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KMAnnals of surgical oncologyThe DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology. Ann Surg Oncol. 2017 Feb; 24(2):362-368.Ann Surg Oncol2016-08-29T00:00:002016The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology.27650684Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MIGynecologic oncologyNeoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecol Oncol. 2016 10; 143(1):3-15.Gynecol Oncol2016-08-08T00:00:002016Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.27743802Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJPractical radiation oncologyImpact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Pract Radiat Oncol. 2017 May - Jun; 7(3):e165-e173.Pract Radiat Oncol2016-09-07T00:00:002016Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy.28131529Suidan RS, He W, Sun CC, Zhao H, Fleming ND, Ramirez PT, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LAGynecologic oncologyImpact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol. 2017 04; 145(1):55-60.Gynecol Oncol2017-01-26T00:00:002017Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia.28029325Meyer LA, Wright AAJournal of clinical oncology : official journal of the American Society of Clinical OncologyReply to M.S. Copur et al. J Clin Oncol. 2017 03; 35(7):803.J Clin Oncol2016-12-28T00:00:002016Reply to M.S. Copur et al.27601552Meyer LA, Cronin AM, Sun CC, Bixel K, Bookman MA, Cristea MC, Griggs JJ, Levenback CF, Burger RA, Mantia-Smaldone G, Matulonis UA, Niland JC, O'Malley DM, Wright AAJournal of clinical oncology : official journal of the American Society of Clinical OncologyUse and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2016 11 10; 34(32):3854-3863.J Clin Oncol2016-11-10T00:00:002016Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.28258763Cohn DE, Ko E, Meyer LA, Wright JD, Temkin SM, Foote J, Jones NL, Havrilesky LJGynecologic oncologyThe "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations. Gynecol Oncol. 2017 04; 145(1):185-191.Gynecol Oncol2017-03-01T00:00:002017The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations.28388292Taylor JS, Rajan SS, Zhang N, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SHJournal of clinical oncology : official journal of the American Society of Clinical OncologyEnd-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer. J Clin Oncol. 2017 Jun 01; 35(16):1829-1835.J Clin Oncol2017-04-07T00:00:002017End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer.28506563Swanick CW, Eifel PJ, Huo J, Meyer LA, Smith GLGynecologic oncologyChallenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer. Gynecol Oncol. 2017 07; 146(1):87-93.Gynecol Oncol2017-05-12T00:00:002017Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer.28574929Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyTreatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer. Int J Gynecol Cancer. 2017 09; 27(7):1350-1359.Int J Gynecol Cancer2017-09-01T00:00:002017Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.29622276Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PTGynecologic oncologyProspective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration. Gynecol Oncol. 2018 06; 149(3):484-490.Gynecol Oncol2018-04-02T00:00:002018Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration.29303933Zhang Y, Coletta AM, Allen PK, Parikh AM, Cox-Mattin M, Meyer LA, Sun CC, Basen-Engquist KM, Lu KH, Klopp AHInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPerirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer. Int J Gynecol Cancer. 2018 02; 28(2):285-292.Int J Gynecol Cancer2018-02-01T00:00:002018Perirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer.29215513Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SNObstetrics and gynecologyTreatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device. Obstet Gynecol. 2018 01; 131(1):109-116.Obstet Gynecol2018-01-01T00:00:002018Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.29995737Meyer LA, Lasala J, Iniesta MD, Nick AM, Munsell MF, Shi Q, Wang XS, Cain KE, Lu KH, Ramirez PTObstetrics and gynecologyEffect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes. Obstet Gynecol. 2018 08; 132(2):281-290.Obstet Gynecol2018-08-01T00:00:002018Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes.30253875Taylor JS, He W, Harrison R, Zhao H, Sun CC, Lu KH, Giordano SH, Meyer LAGynecologic oncologyDisparities in treatment and survival among elderly ovarian cancer patients. Gynecol Oncol. 2018 11; 151(2):269-274.Gynecol Oncol2018-09-22T00:00:002018Disparities in treatment and survival among elderly ovarian cancer patients.29961559Meyer LA, He W, Sun CC, Zhao H, Wright AA, Suidan RS, Dottino J, Alejandro Rauh-Hain J, Lu KH, Giordano SHGynecologic oncologyNeoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness. Gynecol Oncol. 2018 09; 150(3):451-459.Gynecol Oncol2018-06-29T00:00:002018Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness.30095787Fleming ND, Nick AM, Coleman RL, Westin SN, Ramirez PT, Soliman PT, Fellman B, Meyer LA, Schmeler KM, Lu KH, Sood AKObstetrics and gynecologyLaparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer. Obstet Gynecol. 2018 09; 132(3):545-554.Obstet Gynecol2018-09-01T00:00:002018Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.30579568Rauh-Hain JA, Hidrue MK, Gaccione P, Melamed A, Meyer LA, Keating NL, Giordano SH, Rice LW, Birrer MJ, Del Carmen MGGynecologic oncologyVariation in resource utilization associated with the surgical management of ovarian cancer. Gynecol Oncol. 2019 03; 152(3):587-593.Gynecol Oncol2018-12-19T00:00:002018Variation in resource utilization associated with the surgical management of ovarian cancer.D016889Disorders25513340.498673Endometrial NeoplasmsAuthorship 9410147Authorship 9415006Authorship 9416742Authorship 94206510Authorship 9420686Authorship 94240011Authorship 942404130872025Prescott LS, Taylor JS, Enbaya A, Marten CA, Myers KN, Meyer LA, Ramirez PT, Levenback CF, Bodurka DC, Schmeler KMGynecologic oncologyChoosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology. Gynecol Oncol. 2019 06; 153(3):597-603.Gynecol Oncol2019-03-11T00:00:002019Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology.30876486Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LAGynecologic oncologyNational trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer. Gynecol Oncol. 2019 03; 152(3):439-444.Gynecol Oncol2019-03-01T00:00:002019National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer.30876488Taylor JS, Zhang N, Rajan SS, Chavez-MacGregor M, Zhao H, Niu J, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SHGynecologic oncologyHow we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients. Gynecol Oncol. 2019 03; 152(3):452-458.Gynecol Oncol2019-03-01T00:00:002019How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients.30876494Wang XS, Shi Q, Williams LA, Cleeland CS, Garcia-Gonzalez A, Chen TY, Shahid DR, Ramirez PT, Iniesta MD, Siverand AM, Meyer LAGynecologic oncologyValidation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN). Gynecol Oncol. 2019 03; 152(3):492-500.Gynecol Oncol2019-03-01T00:00:002019Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).30876495Meyer LA, Shi Q, Lasala J, Iniesta MD, Lin HK, Nick AM, Williams L, Sun C, Wang XS, Lu KH, Ramirez PTGynecologic oncologyComparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery. Gynecol Oncol. 2019 03; 152(3):501-508.Gynecol Oncol2019-03-01T00:00:002019Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery.30876497Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SKGynecologic oncologyWomen's preferences for cancer risk management strategies in Lynch syndrome. Gynecol Oncol. 2019 03; 152(3):514-521.Gynecol Oncol2019-03-01T00:00:002019Women's preferences for cancer risk management strategies in Lynch syndrome.30877144Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena G, Scott M, Gillis C, Elias K, Wijk L, Huang J, Nygren J, Ljungqvist O, Ramirez PT, Dowdy SCInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyGuidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer. 2019 05; 29(4):651-668.Int J Gynecol Cancer2019-03-15T00:00:002019Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update.Authorship 9428893Authorship 942904130902370Hillman RT, Sanchez-Migallon A, Meyer LA, Iniesta MD, Cain KE, Siverand AM, Veum SPL, Suki TS, Lasala JD, Ramirez PTGynecologic oncologyPatient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program. Gynecol Oncol. 2019 06; 153(3):604-609.Gynecol Oncol2019-03-20T00:00:002019Patient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program.30906877Meyer L, Suidan R, Sun C, Westin S, Coleman RL, Mills GBExpert review of quality of life in cancer careThe management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer. Expert Rev Qual Life Cancer Care. 2016; 1(3):231-238.Expert Rev Qual Life Cancer Care2016-05-27T00:00:002016The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer.Authorship 943983929889752Suidan RS, Sun CC, Cantor SB, Mariani A, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LAObstetrics and gynecologyThree Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis. Obstet Gynecol. 2018 07; 132(1):52-58.Obstet Gynecol2018-07-01T00:00:002018Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis.Authorship 944696930965052Suidan RS, He W, Sun CC, Zhao H, Rauh-Hain JA, Fleming ND, Lu KH, Giordano SH, Meyer LAAmerican journal of obstetrics and gynecologyTotal and out-of-pocket costs of different primary management strategies in ovarian cancer. Am J Obstet Gynecol. 2019 08; 221(2):136.e1-136.e9.Am J Obstet Gynecol2019-04-06T00:00:002019Total and out-of-pocket costs of different primary management strategies in ovarian cancer.D0000710663357900.655287Patient Reported Outcome MeasuresAuthorship 9477711131128110Harrison RF, He W, Fu S, Zhao H, Sun CC, Suidan RS, Woodard TL, Rauh-Hain JA, Westin SN, Giordano SH, Meyer LAAmerican journal of obstetrics and gynecologyNational patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia. Am J Obstet Gynecol. 2019 11; 221(5):474.e1-474.e11.Am J Obstet Gynecol2019-05-22T00:00:002019National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.Authorship 95006610Authorship 950084731207237Gockley A, Melamed A, Cronin A, Bookman MA, Burger RA, Cristae MC, Griggs JJ, Mantia-Smaldone G, Matulonis UA, Meyer LA, Niland J, O'Malley DM, Wright AAAmerican journal of obstetrics and gynecologyOutcomes of secondary cytoreductive surgery for?patients with platinum-sensitive recurrent ovarian?cancer. Am J Obstet Gynecol. 2019 12; 221(6):625.e1-625.e14.Am J Obstet Gynecol2019-06-14T00:00:002019Outcomes of secondary cytoreductive surgery for?patients with platinum-sensitive recurrent ovarian?cancer.31208738Dottino JA, He W, Sun CC, Zhao H, Fu S, Lu KH, Meyer LAGynecologic oncologyCenters for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes. Gynecol Oncol. 2019 08; 154(2):405-410.Gynecol Oncol2019-06-14T00:00:002019Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes.Authorship 9532461031376395Harrison RF, Li Y, Guzman A, Pitcher B, Rodriguez-Restrepo A, Cain KE, Iniesta MD, Lasala JD, Ramirez PT, Meyer LAAmerican journal of obstetrics and gynecologyImpact of implementation of an enhanced recovery program in gynecologic surgery on healthcare costs. Am J Obstet Gynecol. 2020 01; 222(1):66.e1-66.e9.Am J Obstet Gynecol2019-07-31T00:00:002019Impact of implementation of an enhanced recovery program in gynecologic surgery on healthcare costs.Authorship 957011931601647Iniesta MD, Lasala J, Mena G, Rodriguez-Restrepo A, Salvo G, Pitcher B, Washington LD, Harris M, Meyer LA, Ramirez PTInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyImpact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery. Int J Gynecol Cancer. 2019 11; 29(9):1417-1424.Int J Gynecol Cancer2019-10-09T00:00:002019Impact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery.Authorship 957260731613720Zhukovsky DS, Soliman PT, Mathew B, Mills S, Bodurka D, Frumovitz M, Meyer LA, Westin S, Nowitz M, Archie L, Fenton S, Lang K, Williams JL, Boving V, Bruera EJournal of oncology practiceSystematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center. J Oncol Pract. 2019 12; 15(12):e1092-e1097.J Oncol Pract2019-10-15T00:00:002019Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center.Authorship 9627081031843871Harrison R, Zhao H, Sun CC, Fu S, Armbruster SD, Westin SN, Rauh-Hain JA, Lu KH, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyBody mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment. Int J Gynecol Cancer. 2020 02; 30(2):187-192.Int J Gynecol Cancer2019-12-15T00:00:002019Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment.Authorship 975322731911539Stewart KI, Eska JS, Harrison RF, Suidan R, Abraham A, Chisholm GB, Meyer LA, Westin SN, Fleming ND, Frumovitz M, Aloia TA, Soliman PTInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyImplementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges. Int J Gynecol Cancer. 2020 03; 30(3):352-357.Int J Gynecol Cancer2020-01-06T00:00:002020Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges.Authorship 988747232371426Segarra B, Meyer LA, Malpica A, Bhosale PInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyEndometrial cancer recurrence at multiple port sites. Int J Gynecol Cancer. 2020 06; 30(6):893-896.Int J Gynecol Cancer2020-05-04T00:00:002020Endometrial cancer recurrence at multiple port sites.Authorship 992094232553657Charlton-Ouw KM, Meyer LAJournal of vascular surgery. Venous and lymphatic disordersReply. J Vasc Surg Venous Lymphat Disord. 2020 07; 8(4):699-700.J Vasc Surg Venous Lymphat Disord2020-07-01T00:00:002020Reply.Authorship 9931652Authorship 9931821032615101Hinchcliff EM, Meyer LA, Westin SNThe Lancet. OncologyHas dose-dense chemotherapy met an ICONic end? Lancet Oncol. 2020 07; 21(7):869-870.Lancet Oncol2020-07-01T00:00:002020Has dose-dense chemotherapy met an ICONic end?32616627Dottino JA, He W, Sun CC, Zhao H, Fu S, Rauh-Hain JA, Suidan RS, Lu KH, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyNational trends in bowel and upper abdominal procedures in ovarian cancer surgery. Int J Gynecol Cancer. 2020 08; 30(8):1195-1202.Int J Gynecol Cancer2020-07-02T00:00:002020National trends in bowel and upper abdominal procedures in ovarian cancer surgery.Authorship 994864132682856Meyer LA, Corzo C, Iniesta MD, Munsell M, Shi Q, Pitcher B, Lasala J, Cain KE, Wang XS, Mena G, Ramirez PTAmerican journal of obstetrics and gynecologyA prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathway. Am J Obstet Gynecol. 2021 01; 224(1):70.e1-70.e11.Am J Obstet Gynecol2020-07-16T00:00:002020A prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathway.Authorship 998061932848023Harrison R, Iniesta MD, Pitcher B, Ramirez PT, Cain K, Siverand AM, Mena G, Lasala J, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyEnhanced recovery for obese patients undergoing gynecologic cancer surgery. Int J Gynecol Cancer. 2020 10; 30(10):1595-1602.Int J Gynecol Cancer2020-08-26T00:00:002020Enhanced recovery for obese patients undergoing gynecologic cancer surgery.Authorship 1003243633085092Liu W, Qdaisat A, Ferrarotto R, Fuller CD, Guo M, Meyer LA, Narayanan S, Lopez G, Cohen L, Bruera E, Hanna EY, Yeung SJCancerHypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation. Cancer. 2021 02 15; 127(4):528-534.Cancer2020-10-21T00:00:002020Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation.Authorship 10045643Authorship 100464813Authorship 1004982533158876Hillman RT, Iniesta MD, Shi Q, Suki T, Chen T, Cain K, Williams L, Wang XS, Taylor JS, Mena G, Lasala J, Ramirez PT, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyLongitudinal patient-reported outcomes and restrictive opioid prescribing after minimally invasive gynecologic surgery. Int J Gynecol Cancer. 2021 01; 31(1):114-121.Int J Gynecol Cancer2020-11-06T00:00:002020Longitudinal patient-reported outcomes and restrictive opioid prescribing after minimally invasive gynecologic surgery.33154095Fleming ND, Westin SN, Meyer LA, Shafer A, Rauh-Hain JA, Onstad M, Cobb L, Bevers M, Fellman BM, Burzawa J, Bhosale P, Zand B, Jazaeri A, Levenback C, Coleman RL, Soliman PT, Sood AKInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyCorrelation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer. Int J Gynecol Cancer. 2021 01; 31(1):92-97.Int J Gynecol Cancer2020-11-05T00:00:002020Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer.33183765Nitecki R, Fu S, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Rauh-Hain JAGynecologic oncologyEmployment disruption following the diagnosis of endometrial cancer. Gynecol Oncol. 2021 01; 160(1):199-205.Gynecol Oncol2020-11-09T00:00:002020Employment disruption following the diagnosis of endometrial cancer.Authorship 10066471033298309Cain KE, Iniesta MD, Fellman BM, Suki TS, Siverand A, Corzo C, Lasala JD, Cata JP, Mena GE, Meyer LA, Ramirez PTGynecologic oncologyEffect of preoperative intravenous vs oral acetaminophen on postoperative opioid consumption in an enhanced recovery after surgery (ERAS) program in patients undergoing open gynecologic oncology surgery. Gynecol Oncol. 2021 02; 160(2):464-468.Gynecol Oncol2020-12-06T00:00:002020Effect of preoperative intravenous vs oral acetaminophen on postoperative opioid consumption in an enhanced recovery after surgery (ERAS) program in patients undergoing open gynecologic oncology surgery.Authorship 10074431033348030Zhukovsky DS, Haider A, Williams JL, Naqvi S, Joshi N, Mills S, Soliman PT, Mathew B, Bodurka D, Meyer LA, Westin S, Frumovitz M, Nowitz MB, Archie L, Fenton S, Lang K, Boving V, Bruera EJournal of pain and symptom managementAn Integrated Approach to Selecting a Prepared Medical Decision-Maker. J Pain Symptom Manage. 2021 06; 61(6):1305-1310.J Pain Symptom Manage2020-12-24T00:00:002020An Integrated Approach to Selecting a Prepared Medical Decision-Maker.Authorship 10093631033483432Lasala J, Mena GE, Iniesta MD, Cata J, Pitcher B, Wendell W, Zorrilla-Vaca A, Cain K, Basabe M, Suki T, Meyer LA, Ramirez PTInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyImpact of anesthesia technique on post-operative opioid use in open gynecologic surgery in an enhanced recovery after surgery pathway. Int J Gynecol Cancer. 2021 04; 31(4):569-574.Int J Gynecol Cancer2021-01-22T00:00:002021Impact of anesthesia technique on post-operative opioid use in open gynecologic surgery in an enhanced recovery after surgery pathway.Authorship 101054210Authorship 1010548933536126Harrison RF, Cantor SB, Sun CC, Villanueva M, Westin SN, Fleming ND, Toumazis I, Sood AK, Lu KH, Meyer LAGynecologic oncologyCost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer. Gynecol Oncol. 2021 04; 161(1):56-62.Gynecol Oncol2021-01-31T00:00:002021Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer.33536127Wang XS, Kamal M, Chen TH, Shi Q, Garcia-Gonzalez A, Iniesta MD, Cleeland CS, Gottumukkala V, Meyer LAGynecologic oncologyAssessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery. Gynecol Oncol. 2021 04; 161(1):83-88.Gynecol Oncol2021-01-31T00:00:002021Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery.Authorship 10108227Authorship 10108611633549538Harrison RF, Fu S, Sun CC, Zhao H, Lu KH, Giordano SH, Meyer LAAmerican journal of obstetrics and gynecologyPatient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer. Am J Obstet Gynecol. 2021 07; 225(1):68.e1-68.e11.Am J Obstet Gynecol2021-02-04T00:00:002021Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.33551196Coleman RL, Hu W, Soliman P, Nick A, Ramirez PT, Westin SN, Garcia ME, Zhu Z, Palancia J, Fellman BM, Yuan Y, Ram P, Bischoff F, Schmeler K, Bodurka D, Meyer LA, Sood AKGynecologic oncologyDasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study. Gynecol Oncol. 2021 04; 161(1):104-112.Gynecol Oncol2021-02-04T00:00:002021Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study.Authorship 1016099733838925Fleming ND, Westin SN, Rauh-Hain JA, Soliman PT, Fellman BM, Coleman RL, Meyer LA, Shafer A, Cobb LP, Jazaeri A, Lu KH, Sood AKGynecologic oncologyFactors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer. Gynecol Oncol. 2021 07; 162(1):65-71.Gynecol Oncol2021-04-07T00:00:002021Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer.Authorship 1016558433867146Nitecki R, Fleming ND, Fellman BM, Meyer LA, Sood AK, Lu KH, Rauh-Hain JAGynecologic oncologyTiming of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol. 2021 06; 161(3):660-667.Gynecol Oncol2021-04-16T00:00:002021Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer.Authorship 101783610Authorship 1017916233957660Nitecki R, Clapp MA, Fu S, Lamiman K, Melamed A, Brady PC, Kaimal A, Del Carmen MG, Woodard TL, Meyer LA, Giordano SH, Ramirez PT, Rauh-Hain JAObstetrics and gynecologyOutcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer. Obstet Gynecol. 2021 06 01; 137(6):1109-1118.Obstet Gynecol2021-06-01T00:00:002021Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer.33962996Harrison RF, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyFinancial toxicity is common among gynecologic cancer patients. Int J Gynecol Cancer. 2021 06; 31(6):807.Int J Gynecol Cancer2021-05-07T00:00:002021Financial toxicity is common among gynecologic cancer patients.Authorship 10212941334135073Huepenbecker S, Hillman RT, Iniesta MD, Chen T, Cain K, Mena G, Lasala J, Wang XS, Williams L, Taylor JS, Lu KH, Ramirez PT, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyImpact of a tiered discharge opioid algorithm on prescriptions and patient-reported outcomes after open gynecologic surgery. Int J Gynecol Cancer. 2021 07; 31(7):1052-1060.Int J Gynecol Cancer2021-06-16T00:00:002021Impact of a tiered discharge opioid algorithm on prescriptions and patient-reported outcomes after open gynecologic surgery.Authorship 1027224734347287Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Giordano SH, Meyer LACancerFactors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States. Cancer. 2021 Nov 15; 127(22):4151-4160.Cancer2021-08-04T00:00:002021Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.Authorship 1027892934400005Huepenbecker SP, Iniesta MD, Zorrilla-Vaca A, Ramirez PT, Cain KE, Vaughn M, Cata JP, Mena GE, Lasala J, Meyer LAGynecologic oncologyIncidence of acute kidney injury after open gynecologic surgery in an enhanced recovery after surgery pathway. Gynecol Oncol. 2021 10; 163(1):191-198.Gynecol Oncol2021-08-13T00:00:002021Incidence of acute kidney injury after open gynecologic surgery in an enhanced recovery after surgery pathway.Authorship 10296862534518313Westin SN, Labrie M, Litton JK, Blucher A, Fang Y, Vellano CP, Marszalek JR, Feng N, Ma X, Creason A, Fellman B, Yuan Y, Lee S, Kim TB, Liu J, Chelariu-Raicu A, Chen TH, Kabil N, Soliman PT, Frumovitz M, Schmeler KM, Jazaeri A, Lu KH, Murthy R, Meyer LA, Sun CC, Sood AK, Coleman RL, Mills GBClinical cancer research : an official journal of the American Association for Cancer ResearchPhase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clin Cancer Res. 2021 12 01; 27(23):6354-6365.Clin Cancer Res2021-09-13T00:00:002021Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.Authorship 10312241234623068Nitecki R, Floyd J, Lamiman K, Clapp MA, Fu S, Jorgensen K, Melamed A, Brady PC, Kaimal A, Del Carmen MG, Woodard TL, Meyer LA, Giordano SH, Ramirez PT, Rauh-Hain JAObstetrics and gynecologyOutcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Cervical Cancer. Obstet Gynecol. 2021 10 01; 138(4):565-573.Obstet Gynecol2021-10-01T00:00:002021Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Cervical Cancer.Authorship 1034239734785522Nitecki R, Fu S, Jorgensen KA, Gray L, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Ramirez PT, Rauh-Hain JAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyEmployment disruption among women with gynecologic cancers. Int J Gynecol Cancer. 2022 01; 32(1):69-78.Int J Gynecol Cancer2021-11-16T00:00:002021Employment disruption among women with gynecologic cancers.Authorship 10384627Authorship 10388468Authorship 10406742Authorship 1041594235297648Huepenbecker SP, Zhao H, Sun CC, Fu S, He W, Giordano SH, Meyer LAJCO clinical cancer informaticsAlgorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data. JCO Clin Cancer Inform. 2022 03; 6:e2100187.JCO Clin Cancer Inform2022-03-01T00:00:002022Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data.35176166Huepenbecker SP, Meyer LAJournal of the National Cancer InstituteHow Can We Pursue Equity in Cervical Cancer Prevention With Existing HPV Genotype Differences? J Natl Cancer Inst. 2022 06 13; 114(6):787-789.J Natl Cancer Inst2022-06-13T00:00:002022How Can We Pursue Equity in Cervical Cancer Prevention With Existing HPV Genotype Differences?35346424Huepenbecker SP, Meyer LAGynecologic oncologyOur dual responsibility of improving quality and questioning the metrics: Reflections on 30-day readmission rate as a quality indicator. Gynecol Oncol. 2022 04; 165(1):1-3.Gynecol Oncol2022-04-01T00:00:002022Our dual responsibility of improving quality and questioning the metrics: Reflections on 30-day readmission rate as a quality indicator.35331992Huepenbecker SP, Sun CC, Fu S, Zhao H, He W, Primm K, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyTemporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States. Int J Gynecol Cancer. 2022 07 04; 32(7):899-905.Int J Gynecol Cancer2022-07-04T00:00:002022Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States.Authorship 1044955735500609Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LAAmerican journal of obstetrics and gynecologyMedicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis. Am J Obstet Gynecol. 2022 09; 227(3):482.e1-482.e15.Am J Obstet Gynecol2022-04-29T00:00:002022Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis.Authorship 1046410535599168Handley KF, Sood AK, Molin GZD, Westin SN, Meyer LA, Fellman B, Soliman PT, Coleman RL, Fleming NDGynecologic oncologyFrailty repels the knife: The impact of frailty index on surgical intervention and outcomes. Gynecol Oncol. 2022 07; 166(1):50-56.Gynecol Oncol2022-05-20T00:00:002022Frailty repels the knife: The impact of frailty index on surgical intervention and outcomes.Authorship 1049986635803608Huepenbecker S, Sant?a MC, Harrison R, Dos Reis R, Pareja R, Iniesta MD, Meyer LA, Frumovitz M, Zorrilla-Vaca A, Ramirez PTInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyImpact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer. Int J Gynecol Cancer. 2022 Jul 08.Int J Gynecol Cancer2022-07-08T00:00:002022Impact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer.Authorship 105127810Authorship 1051554635882447Fix SM, Forget MA, Sakellariou-Thompson D, Wang Y, Griffiths TM, Lee M, Haymaker CL, Dominguez AL, Basar R, Reyes C, Kumar S, Meyer LA, Hwu P, Bernatchez C, Jazaeri AAJournal for immunotherapy of cancerCRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-? signaling. J Immunother Cancer. 2022 07; 10(7).J Immunother Cancer2022-07-01T00:00:002022CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-? signaling.35871117Primm KM, Huepenbecker SP, Zhao H, Sun CC, Hernandez DC, Meyer LA, Chang SAmerican journal of preventive medicineImpacts of Medicaid Expansion on Stage at Cancer Diagnosis by Patient Insurance Type. Am J Prev Med. 2022 Dec; 63(6):915-925.Am J Prev Med2022-07-21T00:00:002022Impacts of Medicaid Expansion on Stage at Cancer Diagnosis by Patient Insurance Type.Authorship 10612627Authorship 10597143Authorship 10593839Authorship 10563697Authorship 10600567Authorship 10600297Authorship 106095110Authorship 105666519Authorship 1062608836202425Hayek J, Zorrilla-Vaca A, Meyer LA, Mena G, Lasala J, Iniesta MD, Suki T, Huepenbecker S, Cain K, Garcia-Lopez J, Ramirez PTInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPatient outcomes and adherence to an enhanced recovery pathway for open gynecologic surgery: a 6-year single-center experience. Int J Gynecol Cancer. 2022 Oct 06.Int J Gynecol Cancer2022-10-06T00:00:002022Patient outcomes and adherence to an enhanced recovery pathway for open gynecologic surgery: a 6-year single-center experience.36270831Hinchcliff E, Rumpf J, Ratan R, Fleming ND, Jazaeri A, Fellman B, Meyer L, Soliman PGynecologic oncologyHormone receptor status and the role of oophorectomy in uterine leiomyosarcoma. Gynecol Oncol. 2022 Oct 18.Gynecol Oncol2022-10-18T00:00:002022Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma.36481644Sidey-Gibbons CJ, Sun C, Schneider A, Lu SC, Lu K, Wright A, Meyer LScientific reportsPredicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data. Sci Rep. 2022 12 08; 12(1):21269.Sci Rep2022-12-08T00:00:002022Predicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data.36201776Huepenbecker SP, Wright JD, Downer MK, Incerti D, Luhn P, Dolado I, Bastiere-Truchot L, Lin YG, Chan JK, Meyer LAObstetrics and gynecologyTemporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer. Obstet Gynecol. 2022 11 01; 140(5):758-767.Obstet Gynecol2022-10-05T00:00:002022Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer.36310311Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LAAnnals of surgical oncologyMedicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer: A Difference-in-Difference Analysis. Ann Surg Oncol. 2023 Mar; 30(3):1508-1519.Ann Surg Oncol2022-10-30T00:00:002022Medicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer: A Difference-in-Difference Analysis.36224506Zorrilla-Vaca A, Ramirez PT, Iniesta-Donate M, Lasala JD, Wang XS, Williams LA, Meyer L, Mena GECanadian journal of anaesthesia = Journal canadien d'anesthesieOpioid-sparing anesthesia and patient-reported outcomes after open gynecologic surgery: a historical cohort study. Can J Anaesth. 2022 12; 69(12):1477-1492.Can J Anaesth2022-10-12T00:00:002022Opioid-sparing anesthesia and patient-reported outcomes after open gynecologic surgery: a historical cohort study.36324592Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RNFrontiers in oncologyNeoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma. Front Oncol. 2022; 12:1001150.Front Oncol2022-10-17T00:00:002022Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.36166208Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Rauh-Hain JA, Fleming ND, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyAssociation between time to diagnosis, time to treatment, and ovarian cancer survival in the United States. Int J Gynecol Cancer. 2022 09 06; 32(9):1153-1163.Int J Gynecol Cancer2022-09-06T00:00:002022Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States.36600503Wang XS, Ramirez PT, Shi Q, Kamal M, Garcia-Gonzalez A, Iniesta MD, Cleeland CS, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPatient-reported symptoms at discharge and risk of complications after gynecologic surgery. Int J Gynecol Cancer. 2023 02 06; 33(2):271-277.Int J Gynecol Cancer2023-02-06T00:00:002023Patient-reported symptoms at discharge and risk of complications after gynecologic surgery.Authorship 1063583636758422Liang MI, Harrison R, Aviki EM, Esselen KM, Nitecki R, Meyer LGynecologic oncologyFinancial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens. Gynecol Oncol. 2023 03; 170:317-327.Gynecol Oncol2023-02-07T00:00:002023Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens.Authorship 1064388636836508Cata JP, Hu J, Feng L, Chung C, Woodman SE, Meyer LAJournal of personalized medicineAssociation between COVID-19 and Postoperative Neurological Complications and Antipsychotic Medication Use after Cancer Surgery: A Retrospective Study. J Pers Med. 2023 Jan 31; 13(2).J Pers Med2023-01-31T00:00:002023Association between COVID-19 and Postoperative Neurological Complications and Antipsychotic Medication Use after Cancer Surgery: A Retrospective Study.Authorship 10649741036863760Vranes C, Zhao H, Noer MC, Fu S, Sun CC, Harrison R, Ramirez PT, H?gdall CK, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietySecondary validation of an ovarian cancer-specific comorbidity index in a US population. Int J Gynecol Cancer. 2023 05 01; 33(5):749-754.Int J Gynecol Cancer2023-05-01T00:00:002023Secondary validation of an ovarian cancer-specific comorbidity index in a US population.Authorship 1070824737150284Taylor JS, Iniesta MD, Zorrilla-Vaca A, Cain KE, Lasala JD, Mena GE, Meyer LA, Ramirez PTAmerican journal of obstetrics and gynecologyRate of venous thromboembolism on an enhanced recovery program after gynecologic surgery. Am J Obstet Gynecol. 2023 08; 229(2):140.e1-140.e7.Am J Obstet Gynecol2023-05-05T00:00:002023Rate of venous thromboembolism on an enhanced recovery program after gynecologic surgery.Authorship 10808982837827271Huepenbecker SP, Iniesta MD, Wang XS, Cain KE, Zorrilla-Vaca A, Shen SE, Basabe MS, Suki T, Garcia Lopez JE, Mena GE, Lasala JD, Williams LA, Ramirez PT, Meyer LAAmerican journal of obstetrics and gynecologyLongitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy. Am J Obstet Gynecol. 2024 Feb; 230(2):241.e1-241.e18.Am J Obstet Gynecol2023-10-11T00:00:002023Longitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy.Authorship 10838462038009662Hinchcliff EM, Knisely A, Adjei N, Fellman B, Yuan Y, Patel A, Xu C, Westin SN, Sood AK, Soliman PT, Shafer A, Fleming ND, Gershenson DM, Vikram R, Bathala T, Vining D, Ganeshan DM, Lu KH, Sun CC, Meyer LA, Jazaeri AACancerRandomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer. 2024 04 01; 130(7):1061-1071.Cancer2023-11-27T00:00:002023Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.Authorship 10852531238123191Basabe MS, Suki TS, Munsell MF, Iniesta MD, Garcia Lopez JE, Hillman RT, Cain K, Huepenbecker S, Mena G, Taylor JS, Ramirez PT, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyEvaluation of a tiered opioid prescription algorithm in an ERAS pathway: exploring opportunities for further refinement. Int J Gynecol Cancer. 2023 Dec 20.Int J Gynecol Cancer2023-12-20T00:00:002023Evaluation of a tiered opioid prescription algorithm in an ERAS pathway: exploring opportunities for further refinement.Authorship 1085825838141533Pozzar RA, Wall JA, Tavormina A, Thompson E, Enzinger AC, Matulonis UA, Campos S, Meyer LA, Wright AAGynecologic oncologyExperiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers. Gynecol Oncol. 2024 Feb; 181:68-75.Gynecol Oncol2023-12-22T00:00:002023Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers.Authorship 1088194238301188Liu W, Meyer L, Morse M, Li Y, Song J, Engle R, Lopez G, Narayanan S, Soliman PT, Ramondetta L, Bruera E, Cohen LJCO oncology practiceDietary Magnesium Replacement for Prevention of Hypomagnesemia in Patients With Ovarian Cancer Receiving Carboplatin-Based Chemotherapy. JCO Oncol Pract. 2024 Feb 01; OP2300660.JCO Oncol Pract2024-02-01T00:00:002024Dietary Magnesium Replacement for Prevention of Hypomagnesemia in Patients With Ovarian Cancer Receiving Carboplatin-Based Chemotherapy.Authorship 10893406Authorship 1089472438368180Knisely A, Iniesta MD, Batman S, Meyer LA, Soliman PT, Cain KE, Marten C, Chisholm G, Schmeler KM, Taylor JS, Fleming NDGynecologic oncologyEfficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center. Gynecol Oncol. 2024 Feb 16.Gynecol Oncol2024-02-16T00:00:002024Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center.38377761Suidan RS, Sun CC, Schneider AK, Lu KH, Giordano SH, Meyer LAGynecologic oncologyDetermination of quality of life-related health utilities for surgical complications in ovarian cancer. Gynecol Oncol. 2024 Feb 19; 185:101-107.Gynecol Oncol2024-02-19T00:00:002024Determination of quality of life-related health utilities for surgical complications in ovarian cancer.Authorship 10912591238498792Kamboj M, Bohlke K, Baptiste DM, Dunleavy K, Fueger A, Jones L, Kelkar AH, Law LY, LeFebvre KB, Ljungman P, Miller ED, Meyer LA, Moore HN, Soares HP, Taplitz RA, Woldetsadik ES, Kohn ECJournal of clinical oncology : official journal of the American Society of Clinical OncologyVaccination of Adults With Cancer: ASCO Guideline. J Clin Oncol. 2024 Mar 18; JCO2400032.J Clin Oncol2024-03-18T00:00:002024Vaccination of Adults With Cancer: ASCO Guideline.true1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor